Search Results - "Tan, Var"
-
1
Immunomodulatory Roles of PACAP and VIP: Lessons from Knockout Mice
Published in Journal of molecular neuroscience (01-09-2018)“…A bidirectional cross-talk is established between the nervous and immune systems through common mediators including neuropeptides, neurotransmitters, and…”
Get full text
Journal Article -
2
Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases
Published in Frontiers in endocrinology (Lausanne) (22-10-2019)“…Orexins [orexin-A (OXA) and orexin-B (OXB)] are two isoforms of neuropeptides produced by the hypothalamus. The main biological actions of orexins, focused on…”
Get full text
Journal Article -
3
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation
Published in Journal of neuroinflammation (20-03-2019)“…Orexins (hypocretins, Hcrt) A and B are GPCR-binding hypothalamic neuropeptides known to regulate sleep/wake states and feeding behavior. A few studies have…”
Get full text
Journal Article -
4
Class II G protein-coupled receptors for VIP and PACAP: Structure, models of activation and pharmacology
Published in Peptides (New York, N.Y. : 1980) (01-09-2007)“…VIP and PACAP impact strongly on human pathophysiology. Their receptors are very promising targets for developing new drugs in the treatment of inflammatory…”
Get full text
Journal Article -
5
Calcium signaling via Orai1 is essential for induction of the nuclear orphan receptor pathway to drive Th17 differentiation
Published in The Journal of immunology (1950) (01-01-2014)“…Orai1 is the pore subunit of Ca(2+) release-activated Ca(2+) (CRAC) channels that stimulate downstream signaling pathways crucial for T cell activation. CRAC…”
Get full text
Journal Article -
6
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice
Published in Journal of nanobiotechnology (11-01-2024)“…The pro-inflammatory ATP-gated P2X7 receptor is widely expressed by immune and non-immune cells. Nanobodies targeting P2X7, with potentiating or antagonistic…”
Get full text
Journal Article -
7
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
Published in Frontiers in pharmacology (10-10-2022)“…The P2X7 ion channel is a key sensor for extracellular ATP and a key trigger of sterile inflammation. Intravenous injection of nanobodies that block P2X7 has…”
Get full text
Journal Article -
8
Editorial: GPCR in Inflammatory and Cancer Diseases
Published in Frontiers in endocrinology (Lausanne) (25-09-2020)Get full text
Journal Article -
9
Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis
Published in Proceedings of the National Academy of Sciences - PNAS (10-02-2009)“…Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a widely expressed neuropeptide originally discovered in the hypothalamus. It closely resembles…”
Get full text
Journal Article -
10
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist
Published in Psychopharmacology (01-06-2015)“…Rationale An abundance of genetic and epidemiologic evidence as well as longitudinal neuroimaging data point to developmental origins for schizophrenia and…”
Get full text
Journal Article -
11
VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses
Published in PloS one (17-05-2012)“…Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide with immunomodulatory properties. The administration of this peptide has been shown to have…”
Get full text
Journal Article -
12
Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE
Published in PloS one (16-04-2013)“…We have shown that mice deficient in pituitary adenylate cyclase-activating polypeptide (PACAP, gene name ADCYAP1) manifest enhanced sensitivity to…”
Get full text
Journal Article -
13
Targeting VIP and PACAP receptor signalling: new therapeutic strategies in multiple sclerosis
Published in ASN neuro (06-10-2011)“…MS (multiple sclerosis) is a chronic autoimmune and neurodegenerative pathology of the CNS (central nervous system) affecting approx. 2.5 million people…”
Get full text
Journal Article -
14
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction
Published in The FASEB journal (01-05-2012)“…Vasoactive intestinal peptide (VIP) plays a major role in pathophysiology. Our previous studies demonstrated that the VIP sequence 6‐28 interacts with the…”
Get full text
Journal Article -
15
Correction: VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses
Published in PloS one (12-06-2013)“…The following sentence was incorrectly cited: "Interestingly, Yadav et al have recently shown that VPAC1 KO mice present milder DSS-induced colitis compared to…”
Get full text
Journal Article -
16
Diffuse Pharmacophoric Domains of Vasoactive Intestinal Peptide (VIP) and Further Insights into the Interaction of VIP with the N-terminal Ectodomain of Human VPAC1 Receptor by Photoaffinity Labeling with [Bpa6]-VIP
Published in The Journal of biological chemistry (10-09-2004)“…The widespread 28-amino acid neuropeptide vasoactive intestinal peptide (VIP) exerts its many biological effects through interaction with serpentine class II G…”
Get full text
Journal Article -
17
Photoaffinity Labeling Demonstrates Physical Contact between Vasoactive Intestinal Peptide and the N-terminal Ectodomain of the Human VPAC1 Receptor
Published in The Journal of biological chemistry (19-09-2003)“…Vasoactive intestinal peptide (VIP) is a prominent neuropeptide whose actions are mediated by VPAC receptors belonging to class II G protein-coupled receptors…”
Get full text
Journal Article -
18
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis
Published in Proceedings of the National Academy of Sciences - PNAS (09-11-2010)“…The neuropeptide vasoactive intestinal peptide (VIP) has been shown to inhibit macrophage proinflammatory actions, promote a positive Th2/Th1 balance, and…”
Get full text
Journal Article -
19
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses
Published in Brain, behavior, and immunity (01-02-2015)“…Highlights • Loss of VPAC2 receptor results in exacerbated EAE. • Th1 and Th17 responses were enhanced and Th2 diminished in VPAC2 KO mice with EAE. • VPAC2 KO…”
Get full text
Journal Article -
20